Frontlight ResearchEarly access
Liver and biliary tract cancer trials in South Korea
78 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2WithdrawnStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Busan, Daegu, Jinju, Seongnam, Seoul
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - Phase 1/2Active, not recruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Gyeonggi-do, Seoul
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - Phase 2Taking peopleRadioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis
- Where
- Ilsan, Seongnam-si, Seoul
- Age
- 18 years and over
- People
- 30
- Run by
- Seoul National University Hospital
See details and how to joinNCT06166576 - Phase 2Taking peopleRadiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma
- Where
- Seoul
- Age
- 18 years and over
- People
- 30
- Run by
- Seoul National University Hospital
See details and how to joinNCT06178198 - Phase 2Taking peopleBuilding Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria
- Where
- Anyang-si, Gangneung, Ilsan, Seongnam-si, Seoul
- Age
- 19 years and over
- People
- 100
- Run by
- Seoul National University Hospital
See details and how to joinNCT06773845 - Phase 2Not yet taking people in South KoreaAtezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma
- Where
- Seongnam-si
- Age
- 19 years and over
- People
- 51
- Run by
- CHA University
See details and how to joinNCT07774247 - No phaseTaking peopleSame-day Radioembolization for Large HCC
- Where
- Goyang, Seoul
- Age
- 19 years and over
- People
- 138
- Run by
- Seoul National University Hospital
See details and how to joinNCT06944483 - No phaseTaking peopleStreamlining Radioembolization for Small HCC
- Where
- Goyang, Seongnam-si, Seoul
- Age
- 19 years and over
- People
- 146
- Run by
- Seoul National University Hospital
See details and how to joinNCT06979219 - No phaseTaking peopleStreamlining Radioembolization for CCC and Metastatic Liver Cancer
- Where
- Goyang-si, Seoul
- Age
- 19 years and over
- People
- 60
- Run by
- Seoul National University Hospital
See details and how to joinNCT07043387 - Phase 2Taking peoplemFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line
- Where
- Busan, Cheongju-si, Daegu, Gangneung, Hwasun, Incheon, Seongnam-si, Seoul
- Age
- 19 years to 99 years
- People
- 130
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT07062536 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Hwasun, Pusan, Seoul, Suwon
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - Phase 3Not yet taking people in South KoreaFutibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer
- Where
- Busan, Hwasun, Seongnam, Seoul
- Age
- 18 years and over
- People
- 784 worldwide
- Run by
- Taiho Pharmaceutical Co., Ltd.
See details and how to joinNCT07710885 - Phase 2Taking peopleA Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma
- Where
- Seoul
- Age
- 19 years and over
- People
- 33
- Run by
- Asan Medical Center
See details and how to joinNCT07010497 - Phase 1/2Taking peopleClinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 80
- Run by
- Yuhan Corporation
See details and how to joinNCT06975410 - Phase 2Not yet taking people in South KoreaLenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)
- Where
- Seoul
- Age
- 19 years and over
- People
- 146
- Run by
- Asan Medical Center
See details and how to joinNCT07495579 - Phase 2Taking peopleFostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy
- Where
- Seongnam-si
- Age
- 19 years and over
- People
- 80
- Run by
- CHA University
See details and how to joinNCT07493668 - No phaseTaking peopleScout Dose of Resin Microspheres
- Where
- Seoul
- Age
- 19 years and over
- People
- 30
- Run by
- Seoul National University Hospital
See details and how to joinNCT07476651 - No phaseTaking peopleClinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies
- Where
- Seoul
- Age
- 20 years to 85 years
- People
- 128
- Run by
- Seoul National University Hospital
See details and how to joinNCT06426992 - Phase 2Not yet taking people in South KoreaRegorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial
- Where
- Seoul
- Age
- 19 years and over
- People
- 24
- Run by
- Ju Hyun Shim
See details and how to joinNCT07514429 - Phase 2Not yet taking people in South KoreaRegorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients
- Where
- Seoul
- Age
- 19 years to 80 years
- People
- 20
- Run by
- Ju Hyun Shim
See details and how to joinNCT07514455 - Phase 1Taking peopleA Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
- Where
- Goyang-si, Seongnam, Seoul
- Age
- 19 years and over
- People
- 70
- Run by
- Aptamer Sciences, Inc.
See details and how to joinNCT06687941 - No phaseTaking peopleInvestigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
- Where
- Seongnam-si
- Age
- 20 years and over
- People
- 100
- Run by
- CHA University
See details and how to joinNCT06648057 - No phaseTaking peopleRole of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
- Where
- Seongnam-si
- Age
- 19 years and over
- People
- 200
- Run by
- CHA University
See details and how to joinNCT07142226 - No phaseTaking peoplectDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
- Where
- Seongnam-si
- Age
- 19 years and over
- People
- 100
- Run by
- CHA University
See details and how to joinNCT07151118 - No phaseTaking peopleAbbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
- Where
- Seoul
- Age
- 20 years and over
- People
- 455
- Run by
- Asan Medical Center
See details and how to joinNCT06537193